EUVIMEDEUVIMED entdecken
Crossref

Effect of the combination of diuretics, renin–angiotensin–aldosterone system inhibitors, and non‐steroidal anti‐inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case–control study

Dulce Maria Calvo iD, Luis Carlos Saiz iD, Leire Leache iD, Maria Concepción Celaya iD, Marta Gutiérrez-Valencia iD, Alvaro Alonso iD, Juan Erviti iD, Natalia Alzueta iD, Amaya Echeverría iD, Javier Garjón iD, Carmen Fontela iD, Lorea Sanz iD und 3 weitere

Pharmacoepidemiology and Drug Safety · 2023

DOI: 10.1002/pds.5621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2023. Verfasst von Dulce Maria Calvo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Autonomous University of Barcelona (UAB), Barcelona, Spain. Hauptthemen laut MEDLINE: Diuretics, Acute Kidney Injury. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: European Regional Development Fund, Gobierno de Navarra.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Concomitant use of diuretics, renin–angiotensin–aldosterone system (RAAS) inhibitors, and non‐steroidal anti‐inflammatory drugs (NSAIDs) or metamizole, known as ‘triple whammy’ (TW), has been associated with an increased risk of acute kidney injury (AKI). Nevertheless, there is still uncertainty on its impact in hospitalisation and mortality. The aim of the study was to analyse the association between exposure to TW and the risk of hospitalisation for AKI, all‐cause mortality and the need for renal replacement therapy (RRT).

Methods

A case–control study nested in a cohort of adults exposed to at least one diuretic or RAAS inhibitor between 2009 and 2018 was carried out within the Pharmacoepidemiological Research Database for Public Health Systems (BIFAP). Patients hospitalised for AKI between 2010 and 2018 (cases) were matched with up to 10 patients of the same age, sex and region of Spain who had not been hospitalised for AKI as of the date of hospitalisation for AKI of the matching case (controls). The association between TW exposure versus non‐exposure to TW and outcome variables was analysed using logistic regression models.

Results

A total of 480 537 participants (44 756 cases and 435 781 controls) were included (mean age: 79 years). The risk of hospitalisation for AKI was significantly higher amongst those exposed to TW [adjusted odds ratio (aOR) 1.36, 95% confidence interval (95%CI) 1.32–1.40], being higher with current (aOR 1.60, 95%CI 1.52–1.69) and prolonged exposure (aOR 1.65, 95%CI 1.55–1.75). No significant association was found with the need of RRT. Unexpectedly, mortality was lower in those exposed to TW (aOR 0.81, 95%CI 0.71–0.93), which may be influenced by other causes.

Conclusion

Vigilance should be increased when diuretics, RAAS inhibitors, and NSAIDs or metamizole are used concomitantly, especially in patients at risk such as elderly patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiureticsAcute Kidney InjuryAdultHumansAgedRenin-Angiotensin SystemDipyroneCase-Control StudiesAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAnti-Inflammatory Agents, Non-SteroidalHospitalization

Stichwörter der Autor:innen

acute kidney injuryantihypertensivesdiureticsmetamizolenon-steroidal anti-inflammatory agentssafetytriple whammy

Substanzen

DiureticsDipyroneAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Autonomous University of Barcelona (UAB), Barcelona, Spain.
  • Unit of Innovation and Organization, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain.
  • Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain.
  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Pharmacy Service, Donostia University Hospital, OSI Donostialdea, Osakidetza, San Sebastián, Spain.
  • Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Pamplona, Spain.

ORCID-Profile: Dulce Maria Calvo, Luis Carlos Saiz, Leire Leache, Maria Concepción Celaya, Marta Gutiérrez-Valencia, Alvaro Alonso, Juan Erviti, Natalia Alzueta, Amaya Echeverría, Javier Garjón, Carmen Fontela, Lorea Sanz, Maria Teresa Acín, Maria Loreto Fernández, Nerea Gómez

Förderung

  • European Regional Development Fund
  • Gobierno de Navarra

Zitieren

APA

Calvo, D. M., Saiz, L. C., Leache, L., Celaya, M. C., Gutiérrez-Valencia, M., Alonso, A., Erviti, J., Alzueta, N., Echeverría, A., Garjón, J., Fontela, C., Sanz, L., Acín, M. T., Fernández, M. L., & Gómez, N. (2023). Effect of the combination of diuretics, renin–angiotensin–aldosterone system inhibitors, and non‐steroidal anti‐inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case–control study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5621

Vancouver

Calvo DM, Saiz LC, Leache L, Celaya MC, Gutiérrez-Valencia M, Alonso A, et al. Effect of the combination of diuretics, renin–angiotensin–aldosterone system inhibitors, and non‐steroidal anti‐inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case–control study. Pharmacoepidemiology and Drug Safety. 2023. doi:10.1002/pds.5621

BibTeX
@article{Calvo2023,
  author = {Calvo, Dulce Maria and Saiz, Luis Carlos and Leache, Leire and Celaya, Maria Concepción and Gutiérrez-Valencia, Marta and Alonso, Alvaro and Erviti, Juan and Alzueta, Natalia and Echeverría, Amaya and Garjón, Javier and Fontela, Carmen and Sanz, Lorea and Acín, Maria Teresa and Fernández, Maria Loreto and Gómez, Nerea},
  title = {Effect of the combination of diuretics, renin–angiotensin–aldosterone system inhibitors, and non‐steroidal anti‐inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case–control study},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2023},
  doi = {10.1002/pds.5621}
}
Kostenlos starten →